Extracellular RNA signatures of mutant KRAS(G12C) lung adenocarcinoma cells
Khojah, R.; Reggiardo, R.; Ozen, M.; Velandi Maroli, S.; Carrillo, D.; Demirci, U.; Kim, D. H.
Show abstract
Extracellular RNAs (exRNAs) are actively secreted from cells in membrane-bound extracellular vesicles (EVs). Diverse classes of RNAs are secreted as exRNAs, including messenger RNAs (mRNAs), long noncoding RNAs (lncRNAs), and transposable element RNAs (TE RNAs). However, the full composition and clinical utility of exRNAs secreted in response to oncogenic signaling are unknown. Here we use both affinity- and nanofiltration-based EV isolation approaches to show that mutant KRAS(G12C) signaling results in the secretion of specific lncRNAs, TE RNAs, and mRNAs, some of which are prognostic for lung adenocarcinoma (LUAD) patient survival. We found that inhibition of KRAS(G12C) signaling broadly reprograms the noncoding transcriptome, as evidenced by a substantial increase in TE RNA secretion. KRAS(G12C) inhibition also increased the abundance of secreted lncRNAs and retained intron-containing transcripts, while decreasing the mRNA content of EVs. Oncogenic KRAS(G12C) signaling was required for the secretion of mRNAs from a set of 20 genes that are significantly associated with unfavorable clinical outcomes in LUAD. Our study suggests that both coding and noncoding RNAs that are secreted in EVs may serve as KRAS(G12C)-specific signatures for diagnosing lung cancer.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A modular strategy for extracellular vesicle-mediated CRISPR-Cas9 delivery through aptamer-based loading and UV-activated cargo release 95%
- Identification of Novel Scaffold Proteins for Improved Endogenous Engineering of Extracellular Vesicles 94%
- Optimizing Cell Therapy by Sorting Cells with High Extracellular Vesicle Secretion 94%
Similar papers in this journal
- Combining Plasma Extracellular Vesicle Let-7b-5p, miR-184 and Circulating miR-22-3p Levels for NSCLC Diagnosis and Drug Resistance Prediction 96%
- Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indications in a common base culture media system 94%
- Cell type specific long non-coding RNA targets identified by integrative analysis of single-cell and bulk colorectal cancer transcriptomes 94%
Similar papers in this journal
- Charting extracellular transcriptomes in The Human Biofluid RNA Atlas 94%
- RNA Splicing Junction Landscape Reveals Abundant Tumor-Specific Transcripts in Human Cancer 94%
- Antisense oligonucleotide-mediated perturbation of long non-coding RNA reveals functional features in stem cells and across cell types 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.